ArticlePediatric radiology2021
Prognostic significance of pretreatment
Article in Pediatric radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.
- Prognostic prediction byFrontiers in oncology · 2023Pooled it
- Diagnostic Value of Seven Different Imaging Modalities for Patients with Neuroblastic Tumors: A Network Meta-Analysis.Contrast media & molecular imaging · 2021Pooled it
- Characteristics and prognostic value of pre-treatmentEuropean journal of nuclear medicine and molecular imaging · 2026Observational
- Article
- Prognostic value of baseline [68Ga]Ga‑DOTA‑NOC PET/CT in paediatric neuroblastoma.European journal of nuclear medicine and molecular imaging · 2026Article
- Article
- The baselineBMC medical imaging · 2025Article
- The prognostic role ofEuropean radiology · 2024Article
- Whole-tumoral metabolic heterogeneity inCancer imaging : the official publication of the International Cancer Imaging Society · 2024Article
- Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets.International journal of molecular sciences · 2024Review
- Article
- Clinical value ofFrontiers in oncology · 2023Article
- Optimized low-dose positron emission tomography/computed tomography schemes in pediatric tumor patients: a randomized clinical trial.Translational pediatrics · 2022Article
- The prognostic value ofCancer imaging : the official publication of the International Cancer Imaging Society · 2022Article
- Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma.BMC medical imaging · 2022Article
- Prediction for Mitosis-Karyorrhexis Index Status of Pediatric Neuroblastoma via Machine Learning BasedDiagnostics (Basel, Switzerland) · 2022Article
- Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma-Experiences From the GPOH-MET Registry.Frontiers in endocrinology · 2022Article
- Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma.Frontiers in oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background
objectiveThis study explored the prognostic significance of MATERIALS AND
methodsThis retrospective study reviewed all
resultsFifty-five children were included, with a median age of 2.9 years (interquartile range [IQR] 1.8-3.0 years). SUV
conclusionTumor metabolic activity is higher in higher-stage MYCN-amplified neuroblastic tumors. Higher SUV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.